Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominica... (of companies servingthe healthcare indus...)

Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic

Date:9/22/2007

of companies serving the healthcare industry in Colombia. 'Salud Total,' overseeing Magallan, is the third largest health services company in Colombia. Magallan is responsible for location of needed products, Colombian registration with the Health authorities and product distribution.

About Pentafarma CxA

Pentafarma is a pharmaceutical and medical device distributor in the Dominican Republic selling supplies to hospitals in that country. Clients include oncology and gynecological hospitals and surgery centers.

Contact:

Marian Robinson, Vice President, Marketing

Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157

Email: marian.robinson@baxa.com

Maggie Chamberlin Holben, APR

Absolutely Public Relations: 303.984.9801 or 303.669.3558

Email: maggie@absolutelypr.com

Luis Jimenez

Magallan Pharma Trading Corp: 57-12-55-9945

Email: luis.jimenez@magallanpharmatrading.com

Leida Perez

Pentafarma & Co. CXA:

809-227-0322

Fax; 809-563-5143

Email; lperez@pentafarma.net

SOURCE Baxa Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
2. Millipore Corporation Announces New ReNcell Data from Collaboration with ReNeuron
3. NanoBio Corporation Announces Positive Phase 1 Clinical Results for Topical Treatment for Onychomycosis
4. Alba Therapeutics Corporation Reports Preliminary Phase IIa Clinical Trial Results for AT-1001 for the Treatment of Celiac Disease
5. EpiCept Corporation to Present New NP-1 Data at American Pain Society Meeting
6. Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
7. MabThera Significantly Extends Survival And Cures More Patients With Aggressive Lymphoma Than Chemotherapy Alone
8. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
9. New Report Looking at Chiral Technologies Analyzes the Global Market Growth Forecasts Driven By Two Very Important Components as Single Isomer Drugs and Single Enantiomer Pharmaceuticals
10. New Study Reveals Limitations of a Complex and Challenging Global Tuberculosis Drug Marketplace
11. Global Rabies Treatment May be Possible with NanoViricides Drugs

Post Your Comments:

(Date:5/12/2008)...,) to acquire Iomai Corporation (,Iomai,) in a, fu...0 per share of Iomai,s common stock representing...imately USD 189 million (EUR 122 million). Acquisi...xchange for approximately 41 percent of Iomai,s c...rs for,approximately 1.7 million Intercell shares ...

(Date:5/12/2008)...wire-USNewswire/ -- The Alliance for Lupus,Researc...solution,supporting the goals and ideals of Nation...her,s Day. The resolution, introduced by Senators ...s on all Americans to take the,week of May 11th - ...n,women,s health issues, and recognizes the import...

(Date:5/12/2008)...r function like a radio dial, not an on/off,light ...isease may develop,late in life, MEMPHIS, Tenn....ldren,s,Research Hospital study shows that T cells...simple on/off switches to govern the cellular,mach...n. Rather, they,possess sophisticated molecular co...

(Date:5/12/2008)...rological recovery in severely-injured, acute ...h Cethrin, HOPKINTON, Mass., May 12 /PRNewswire-F...: ALSE ) today announced 12-month interim data,fr...oprietary recombinant,protein that is being invest...ory function after spinal cord injury, or SCI. The...

[0] Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation [0] Lupus Under the Spotlight: U.S. Congress Shows Support for Women's Health Issues [0] St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity [0] Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury

... to Help Educate on Good,Diabetes Management and H...lems, SEATTLE, April 10, 2007 /PRNewswire/ -- A fi...nd cost of type 2 diabetes,complications shows tha...ent) with type 2 diabetes have at least one of the... with the disease, and,that these health problems ...

...utilization management,programs, ST. PAUL, Minn., ...nager Prime Therapeutics (Prime) today announced t...era(R) (atomoxetine) for treating,attention defici...tudy found that children who start on Strattera we...han children who started on,stimulants. Due to the...

Other Medicine Technology:First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 2 First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 3 First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 4 First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 5 First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 6 First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 7 Study Shows Children With ADHD Who Start on Strattera are More,Likely to Change Therapies 2 Study Shows Children With ADHD Who Start on Strattera are More,Likely to Change Therapies 3

First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America Study Shows Children With ADHD Who Start on Strattera are More,Likely to Change Therapies

(Date:5/12/2008)...earchers who pioneered treatments which have helpe... other autoimmune diseases have been awarded the p...cal Research, announced today. , Emeritus Profes..., who have been carrying out research together at ...cted for the $100K award by an international commi...

(Date:5/12/2008)...Bermuda and COPENHAGEN, Denmark, May 12,/PRNewswir...ounced today,that the United States Food and Drug ...lication (NDA) for Taclonex Scalp(R) (calcipotrien...pical Suspension. LEO Pharma submitted,the NDA for...ex Scalp(R) is,a topical suspension containing a c...

(Date:5/12/2008)... Calif., May 12 /PRNewswire/ -- Emphasys Medical I...ENT clinical trial of the,company,s Zephyr(R) Endo...ernational Conference of the American Thoracic Soc...da., Sunday, May 18, 9:30-11:00 a.m. (ET), Metro ...osium, "Innovations in Emphysema Treatment: Lung V...

(Date:5/12/2008)...y 12 /PRNewswire-FirstCall/ -- Allied Healthcare P... its net income for the third,quarter ending March..., or,4 cents per share, to about $100,000 in the c...he third quarter increased by about $240,000 compa...r, higher material and labor costs,this fiscal yea...

Breaking Medicine News(10 mins):Health News:Researchers who helped millions with arthritis receive prestigious Janssen Award 2 Health News:Researchers who helped millions with arthritis receive prestigious Janssen Award 3 Health News:Researchers who helped millions with arthritis receive prestigious Janssen Award 4 Health News:FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis 2 Health News:FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis 3 Health News:FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis 4 Health News:Emphasys Medical to Present VENT Clinical Trial Data at ATS 2008 2 Health News:Allied Healthcare Net Falls on Manufacturing Delays 2 Health News:Allied Healthcare Net Falls on Manufacturing Delays 3 Health News:Allied Healthcare Net Falls on Manufacturing Delays 4 Health News:Allied Healthcare Net Falls on Manufacturing Delays 5

[0] Researchers who helped millions with arthritis receive prestigious Janssen Award [0] FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis [0] Emphasys Medical to Present VENT Clinical Trial Data at ATS 2008 [0] Allied Healthcare Net Falls on Manufacturing Delays

...year back, hundreds of patients and doctors were s... hurricane Katrina struck New Orleans.// On the 1-...rts from that hospital. “When you look around at ...you're in a warehouse or some kind of abandoned bu...

...t study from Stanford University has shown that th...briety.// The study appears in the September issue... Past studies had shown that besides the direct ef...do get messed up and these neuropsychological defi...

...old conjoined twins were separated after a lengthy...of the ICU.// According to their father, it is an ...errin were born in February 2002. They were conjoi...organs, including only one kidney and 2 legs. Due ...

...usets third human case of eastern equine encephali...d Middleborough boy.// According to state health ...spitalized. His parents identified him as John Fo...was included in the Massachusets’ first aerial spr...

Other Medicine News:Health News:Long term Sobriety can Reverse Effects of Alcohol Damage 2 Health News:Conjoined twins doing well after separation 2

Charity Hospital - A year after Katrina hit New Orleans…Long term Sobriety can Reverse Effects of Alcohol Damage Conjoined twins doing well after separation Another EEE case confirmed in Massachusets Boy

Each handle is designed to fit a specific trephine size.

Reusable, stainless steel trephine with handle.

Medicine Products:

8.0mm Trephine Handle 6.0mm Trephine Handle 4.0mm Trephine with Handle 1.5mm Trephine with Handle

Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominica...(of companies servingthe healthcare indus...),Health